Australia
Poor Employment Report Only Slows Australian Dollar's Breakout by Dr. Duru
China
China Finance Online's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Social Gaming Stocks: Is Shanda Games Limited A Decent Investment? by StockBaller
The Slow Road To China's Currency Convertibility by MetalMiner
China Hydroelectric Corporation CEO Discusses Q4 2012 Results - Earnings Call Transcript
Yingli Dismantling Its Vertical Integration by Joseph Zhu
Finland
Nokia: Recovery Is Gathering Pace by IAEResearch
France
Market Analysis: France by Hale Stewart
Why Did Alcatel-Lucent Rise 4.2% Wednesday? by Markos Kaminis
India
Infosys Kicks Off Indian And Quasi-Indian IT Earnings Tomorrow Before U.S. Markets Open by Jay Somaney
Japan
Bank Of Japan Losing Control Of Bond Market Spells End Game For Japan by Nicholas Pardini
An Alternative Way To Profit From The Deliberate Devaluation Of The Japanese Yen by Ben Mountifield
The Ripple Effect Of 'Abenomics' by Scott Minerd
Displaced JGB Investors by Marc Chandler
México
Passing On Verizon And AT&T, But America Movil Appears Attractive At Current Levels by 12 Value Stocks
Switzerland
Roche Holding's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Taiwan
Himax Technologies: The Short Case by Dividend Monkey
Canada
BlackBerry's Stock Price Manipulated by Infinity Group
Silver Wheaton: Short-Term Pressure, Long-Term Gains by ONeil Trader
BlackBerry Could Be This Year's Winner by Bill Maurer
Better Alternatives For Agrium While JANA Dispute Lasts by Nick Chiu
Eldorado Gold: Growth And Value by Emmet Kodesh
Silver Wheaton: What Is The Impact Of The Latest Delay At Pascua Lama? by Itinerant
Barrick Gold And The Pascua-Lama Disaster by Mike the PhD
Steer Clear Of The BlackBerry Dog by Jonathan Verenger
BlackBerry: How Can Returns Possibly Exceed Sales by Michael Collins
Commodity Chart Of The Day: Canadian Dollar - North Of The Border by Matthew Bradbard
NovaGold Resources' CEO Discusses Q1 2013 Results - Earnings Call Transcript
3 Reasons Lululemon Is Sexy And It Knows It by Quoth the Raven
DelMar Pharmaceuticals: New, Promising Data For Glioblastoma Drug by Brian L. Wilson
Why are you receiving this? You subscribed to Global Investing at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No comments:
Post a Comment